)
Cryo Cell International (CCEL) investor relations material
Cryo Cell International Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue for the six months ended May 31, 2026 was $15.46M, down 3% year-over-year, mainly due to a decline in new domestic cord blood specimens processed, partially offset by higher recurring storage fees.
Net income for the six months was $601,694, compared to $638,640 in the prior year period.
The company is engaged in ongoing arbitration with Duke University over a terminated license agreement, impacting expansion plans.
Financial highlights
Six-month revenue decreased to $15.46M from $15.90M year-over-year.
Net income for the six months was $601,694, down from $638,640 year-over-year.
Gross margin improved as cost of sales declined 13% to $3.33M.
Operating income for the six months was $1.96M, down from $2.55M year-over-year.
Diluted EPS for the six months was $0.07, compared to $0.08 in the prior year.
Outlook and guidance
The company anticipates sufficient liquidity for at least the next 12 months, with future investments in Duke-related activities on hold pending arbitration outcome.
Expansion into infusion clinics and biopharmaceutical manufacturing is paused.
- Revenue and net income increased, with ongoing R&D, facility expansion, and global growth focus.CCEL
Q2 202410 Jun 2026 - Revenue and net income rose; Celle Corp. spinoff paused, dividend under review.CCEL
Q3 202410 Jun 2026 - Returned to profitability in 2024 with $32M revenue, after prior-year impairment losses.CCEL
Q4 202410 Jun 2026 - Flat six-month revenue, lower net income, and Duke arbitration shape a cautious outlook.CCEL
Q2 202510 Jun 2026 - Revenue up 2% to $7.97M, but net income fell and expansion paused due to Duke arbitration.CCEL
Q1 202510 Jun 2026 - Revenue and net income fell as legal dispute with Duke University paused expansion plans.CCEL
Q3 202510 Jun 2026 - Net loss of $2.4 million in 2025 driven by lower revenue and a $4.4 million inventory impairment.CCEL
Q4 202510 Jun 2026 - Revenue and net income declined amid legal costs, Duke arbitration, and industry risks.CCEL
Q1 202610 Jun 2026 - Shareholders will vote on directors, auditor ratification, and executive pay at the 2025 meeting.CCEL
Proxy filing9 Jun 2026
Next Cryo Cell International earnings date
Next Cryo Cell International earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)